MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN

Biochemical and Biophysical Research Communications

Volumn 434, Issue 3, 2013, Pages 688-694

  Wang, Fang ^a,b   Li, Ting ^a   Zhang, Bin ^c   Li, Hong ^a   Wu, Qiong ^a   Yang, Li ^b   Nie, Yongzhan ^a   Wu, Kaichun ^a   Shi, Yongquan ^a   Fan, Daiming ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NINGXIA MEDICAL UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; MiR 19a b; Multidrug resistance; PTEN

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; MICRORNA; MICRORNA 19A; MICRORNA 19B; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; UNCLASSIFIED DRUG; MIRN19 MICRORNA, HUMAN; PRIMER DNA;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UPREGULATION; ADENOCARCINOMA; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; STOMACH TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

ADENOCARCINOMA; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; DNA PRIMERS; DRUG RESISTANCE, MULTIPLE; HUMANS; MICRORNAS; P-GLYCOPROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; UP-REGULATION;

MLCS; MLOWN;

EID: 84880488920     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.04.010     Document Type: Article

References (34)

1. st century, Crit. Rev. Oncol. Hematol. 57 (2006) 123-131.
2. G. Szakacs, J.K. Paterson, J.A. Ludwig, C. Booth-Genthe, M.M. Gottesman, Targeting multidrug resistance in cancer, Nat. Rev. Drug Discov. 5 (2006) 219-234.
3. R.W. Johnstone, A.A. Ruefli, S.W. Lowe, Apoptosis: a link between cancer genetics and chemotherapy, Cell 108 (2002) 153-164.
4. C.A. Rabik, M.E. Dolan, Molecular mechanisms of resistance and toxicity associated with platinating agents, Cancer Treat. Rev. 33 (2007) 9-23.
5. J. Ma, C. Dong, C. Ji, MicroRNA and drug resistance, Cancer Gene Ther. 17 (2010) 523-531.
6. J. Krutzfeldt, M.N. Poy, M. Stoffel, Strategies to determine the biological function of microRNAs, Nat. Genet. 38 (Suppl.) (2006) S14-S19.
7. T. Zheng, J. Wang, X. Chen, L. Liu, Role of microRNA in anticancer drug resistance, Int. J. Cancer 126 (2010) 2-10.
8. W.C. Cho, OncomiRs: the discovery and progress of microRNAs in cancers, Mol. Cancer 6 (2007) 60.
9. Y. Li, W. Li, Y. Yang, Y. Lu, C. He, G. Hu, H. Liu, J. Chen, J. He, H. Yu, MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme, Brain Res. 1286 (2009) 13-18.
10. L. Xia, D. Zhang, R.Y. Du, L. Pan, S. Zhao, L. Sun, J. Hong, J. Liu, D. Fan, miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells, Int. J. Cancer 123 (2008) 372-379.
11. F. Petrocca, R. Visone, M.R. Onelli, M.H. Shah, M.S. Nicoloso, I. de Martino, D. Iliopoulos, E. Pilozzi, C.G. Liu, M. Negrini, L. Cavazzini, S. Volinia, H. Alder, L.P. Ruco, G. Baldassarre, C.M. Croce, A. Vecchione, E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer, Cancer Cell 13 (2008) 272-286.
12. I. Ivanovska, A.S. Ball, R.L. Diaz, J.F. Magnus, M. Kibukawa, J.M. Schelter, S.V. Kobayashi, L. Lim, J. Burchard, A.L. Jackson, P.S. Linsley, M.A. Cleary, MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression, Mol. Cell Biol. 28 (2008) 2167-2174.
13. C. Chen, D.A. Ridzon, A.J. Broomer, Z. Zhou, D.H. Lee, J.T. Nguyen, M. Barbisin, N.L. Xu, V.R. Mahuvakar, M.R. Andersen, K.Q. Lao, K.J. Livak, K.J. Guegler, Realtime quantification of microRNAs by stem-loop RT-PCR, Nucleic Acids Res. 33 (2005) e179.
14. K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using realtime quantitative PCR and the 2(-Delta Delta C(T)) Method, Methods 25 (2001) 402-408.
15. H. Yamaue, H. Tanimura, K. Noguchi, T. Hotta, M. Tani, T. Tsunoda, M. Iwahashi, M. Tamai, S. Iwakura, Chemosensitivity testing of fresh human gastric cancer with highly purified tumour cells using the MTT assay, Br. J. Cancer 66 (1992) 794-799.
16. H. Yamaue, M. Tani, H. Onishi, H. Kinoshita, M. Nakamori, S. Yokoyama, M. Iwahashi, K. Uchiyama, Locoregional chemotherapy for patients with pancreatic cancer intra-arterial adjuvant chemotherapy after pancreatectomy with portal vein resection, Pancreas 25 (2002) 366-372.
17. Y. Shi, Y. Han, X. Wang, Y. Zhao, X. Ning, B. Xiao, D. Fan, MGr1-Ag is associated with multidrug-resistant phenotype of gastric cancer cells, Gastric Cancer 5 (2002) 154-159.
18. H. Yang, W. Kong, L. He, J.J. Zhao, J.D. O'Donnell, J. Wang, R.M. Wenham, D. Coppola, P.A. Kruk, S.V. Nicosia, J.Q. Cheng, MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN, Cancer Res. 68 (2008) 425-433.
19. M.G. Pezzolesi, P. Platzer, K.A. Waite, C. Eng, Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome, Am. J. Hum. Genet. 82 (2008) 1141-1149.
20. X. Cai, X. Zhang, D. Fan, Establishment of a multidrug-resistant gastric cancer cell line and its biological characteristics (in Chinese with English abstract), Chin. J. Clin. Oncol. 2S (1994) 67-71.
21. Y. Zhao, H. You, F. Liu, H. An, Y. Shi, Q. Yu, D. Fan, Differentially expressed gene profiles between multidrug resistant gastric adenocarcinoma cells and their parental cells, Cancer Lett. 185 (2002) 211-218.
22. X. Wang, M. Lan, Y.Q. Shi, J. Lu, Y.X. Zhong, H.P. Wu, H.H. Zai, J. Ding, K.C. Wu, B.R. Pan, J.P. Jin, D.M. Fan, Differential display of vincristine-resistance-related genes in gastric cancer SGC7901 cell, World J. Gastroenterol. 8 (2002) 54-59.
23. Y.X. Yang, Z.Q. Xiao, Z.C. Chen, G.Y. Zhang, H. Yi, P.F. Zhang, J.L. Li, G. Zhu, Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR, Proteomics 6 (2006) 2009-2021.
24. J.H. Choi, H.Y. Lim, H.J. Joo, H.S. Kim, J.W. Yi, H.C. Kim, Y.K. Cho, M.W. Kim, K.B. Lee, Expression of multidrug resistance-associated protein1, P-glycoprotein, and thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection, Br. J. Cancer 86 (2002) 1578-1585.
25. J. Wallner, D. Depisch, A. Gsur, M. Gotzl, K. Haider, R. Pirker, MDR1 gene expression and its clinical relevance in primary gastric carcinomas, Cancer 71 (1993) 667-671.
26. S.H. Kaufmann, W.C. Earnshaw, Induction of apoptosis by cancer chemotherapy, Exp. Cell Res. 256 (2000) 42-49.
27. P. Michl, J. Downward, Mechanisms of disease: PI3K/AKT signaling in gastrointestinal cancers, Z Gastroenterol. 43 (2005) 1133-1139.
28. Z. Han, L. Hong, Y. Han, K. Wu, S. Han, H. Shen, C. Li, L. Yao, T. Qiao, D. Fan, Phospho Akt mediates multidrug resistance of gastric cancer cells through regulation of P-gp, Bcl-2 and Bax, J. Exp. Clin. Cancer Res. 26 (2007) 261-268.
29. H.G. Yu, Y.W. Ai, L.L. Yu, X.D. Zhou, J. Liu, J.H. Li, X.M. Xu, S. Liu, J. Chen, F. Liu, Y.L. Qi, Q. Deng, J. Cao, S.Q. Liu, H.S. Luo, J.P. Yu, Phosphoinositide 3-kinase/Akt pathway plays an important role in chemoresistance of gastric cancer cells against etoposide and doxorubicin induced cell death, Int. J. Cancer 122 (2008) 433-443.
30. E. Oki, H. Baba, E. Tokunaga, T. Nakamura, N. Ueda, M. Futatsugi, K. Mashino, M. Yamamoto, M. Ikebe, Y. Kakeji, Y. Maehara, Akt phosphorylation associates with LOH of PTEN and leads to chemoresistance for gastric cancer, Int. J. Cancer 117 (2005) 376-380.
31. P.E. Blower, J.S. Verducci, S. Lin, J. Zhou, J.H. Chung, Z. Dai, C.G. Liu, W. Reinhold, P.L. Lorenzi, E.P. Kaldjian, C.M. Croce, J.N. Weinstein, W. Sadee, MicroRNA expression profiles for the NCI-60 cancer cell panel, Mol. Cancer Ther. 6 (2007) 1483-1491.
32. M.T. Kuo, Z. Liu, Y. Wei, Y.C. Lin-Lee, S. Tatebe, G.B. Mills, H. Unate, Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling, Oncogene 21 (2002) 1945-1954.
33. M. Bentires-Alj, V. Barbu, M. Fillet, A. Chariot, B. Relic, N. Jacobs, J. Gielen, M.P. Merville, V. Bours, NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells, Oncogene 22 (2003) 90-97.
34. K. Akiyama, N. Ohga, Y. Hida, T. Kawamoto, Y. Sadamoto, S. Ishikawa, N. Maishi, T. Akino, M. Kondoh, A. Matsuda, N. Inoue, M. Shindoh, K. Hida, Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment, Am. J. Pathol. 180 (2012) 1283-1293.